Hard-to-Reach ElderlyNCT07305441
Impact Assessment of the Jockey Club REACH & Map Program for Hard-to-reach Older Adults
A study testing Mapped intervention based on health status in people with Hard-to-Reach Elderly, run by The University of Hong Kong at 1 site in Hong Kong.
Trial summary
The goal of this study is to evaluate the impact of the Reach-and-Map project on increasing functional capacity to optimize the functional ability of the vulnerable group of "Hard-to-Reach" older adults through increase the compatibility between their intrinsic capacity and environment. Read more about this study
- Who is it for?
- Ages 60 years and olderHealthy volunteers can take part
- Conditions the study is for
- Hard-to-Reach Elderly
- What is being tested?
- Mapped intervention based on health status
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 5,500 participants
- Where
- 1 siteHong Kong
- Study dates
- 5 Feb 2024to 31 Jan 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- age > 60
- able to participate in the impact assessment as evidence by a test score of > 6 on the Abbreviated Mental Test
- has the functional ability to engage in the digital intervention
- able to communicate with the researcher
Who cannot join
- -
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Hong Kong1 site, 1 recruiting
- Recruiting
The University of Hong Kong
Hong Kong
Doris Sau Fung Prof. Yu,, +852 39176319, dyu1@hku.hk
Doris Sau Fung Prof. Yu,
About this study
Official title: Impact Assessment of the Jockey Club REACH & Map Program for Hard-to-reach Older Adults in the Community: A Target Trial Emulation
The goal of this study is to evaluate the impact of the Reach-and-Map project on increasing functional capacity to optimize the functional ability of the vulnerable group of "Hard-to-Reach" older adults through increase the compatibility between their intrinsic capacity and environment.
Read the detailed description
The overall aim of this project is to conduct a comprehensive impact assessment of the Jockey Club (JC) Reach \& Map Program, utilizing a framework based on the World Health Organization (WHO) Health Impact Assessment. The study will evaluate how the program influences health outcomes among hard-to-reach older adults by assessing changes in key health determinants. The findings will be disseminated to relevant stakeholders to inform future policy setting and service planning, and long-term monitoring will be undertaken to evaluate the extent to which the impact assessment influences decision-making in aged care service development.
The primary focus of the evaluation is on the functional abilities of older adults, including physical, cognitive, psychological, and social functioning. The assessment will also cover core outcomes such as quality of life, frailty, and health service use, alongside person-centered measures like loneliness and mental health. Given the diverse services received by beneficiaries, the study will account for structural and social health determinants-such as age, gender, socio-economic status, and chronic disease burden-as covariates in the analysis. In addition, the project will explore the broader effects of the JC Reach \& Map Program on aged care service utilization and document both the experiences of service recipients and stakeholders involved.
Specifically, the study objectives are: (1) to evaluate the impact of the JC Reach \& Map Program on frailty, quality of life, and health service use among hard-to-reach older adults, focusing on physical, cognitive, psychological, and social functions; (2) to explore the engagement experiences and perceptions of older adults regarding the services received, and their impact on well-being, community engagement, and social integration; and (3) to explore the experiences of service stakeholders in reaching and working with this population, as well as to gather their insights on ideal service models and policies for hard-to-reach older adults.
- Conditions
- Hard-to-Reach Elderly
- Being tested
- Mapped intervention based on health status
- Keywords
- Hard-to-Reach, elderly, functional status
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mapped intervention based on health statusBehavioural
Intervention will be conducted to improve lifestyle based on their needs which include 1) Home modification, 2) Lifestyle-based health promotion, 3) Geriatric symptom management, 4) Health counseling for chronic disease management, 5) Counseling-based service, 6) Social network optimization, 7) Social support optimization
| Study group | Role | What they receive |
|---|---|---|
| Treatment status | Experimental | To account for time bias, each subject will be created with two clones at time zero and assigned each of the two clones to either treatment or no-treatment status, respectively. The treatment status in each evaluative endpoint (i.e., 1-month, 4-month, 10-month, and 13-month) is defined as subjects who have received the mapped intervention for the respective length of time since the time zero during which the intervention has just commenced. Receives: Behavioral: Mapped intervention based on health status |
| No-treatment status | No intervention | To account for immortal time bias, each subject will be created with two clones at time zero and assigned each of the two clones to either treatment or no-treatment status, respectively. The corresponding no-treatment status is defined as subjects who have not received any mapped intervention for the corresponding length of time. |
What is being measured
The primary outcome is the main question the study is designed to answer.
EuroQoL-5 Dimension-5 Level
Measuring Health-related quality of life (HRQL) (range from -0.59 to 1.0), higher score indicates better quality of life
Measured: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Short Physical Performance Battery
Measuring by (range from 0 to 12), with higher score indicating better physical performance
Measured: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
5-minute Montreal Cognitive Assessment (MoCA)
Measuring Cognitive function (range from 0 to 30), A score of 26 or over is considered to be normal.
Measured: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
7-item Memory Complaint Scale (MCS)
Measuring Subjective Memory Score (range from 0 to 14), lower score indicates better memory performance. No MCs (0-2), Mild MCs (3-6), Moderate MCs (7-10), Severe MCs (11-14).
Measured: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
3-item University of California, Los Angeles (UCLA) Loneliness Scale
Measuring Loneliness (range 3-9), higher score indicates greater loneliness.
Measured: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
The 8-item Geriatric Depression Scale
Measuring Depression (range 0 to 8), with higher score indicating higher risk of depression
Measured: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
8-item Social Connectedness Scale Revised
Measuring Social connectedness (range 0 to 48), <22 indicates lack of social connectedness
Measured: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Secondary outcomes (2)
Health service utilization
Self-developed checklist on community care service for older adults in Hong Kong
Measured: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Health service utilization
Self-developed checklist on health service utilization (including visit to out-patient clinic, emergency medical service, an in-hospital service in private and/or public sectors).
[generic] With the consent from the participants, the above information will be retrieved from the electronic health record. Otherwise, self-report method will be used for collecting the data.
Measured: From baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Dec 2025
- Study start5 Feb 2024
- Primary completion30 Sep 2027 (estimated)
- Study completion31 Jan 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hard-to-Reach ElderlyStudies of the same condition, open and under way.
- More trials run by The University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 5,500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- The University of Hong Kong
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Prof. Yu, Doris Sau Fung, The University of Hong Kong
- Investigators
- Doris Sau Fung YU, Principal investigator, The University of Hong Kong
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07305441
- Sponsor's protocol ID
- REACH & MAP
- Status last verified
- Dec 2025
- First submitted
- 12 Dec 2025
- Last updated
- 26 Dec 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: There is not a plan to make individual participant data (IPD) available to other researchers.
Study at a glance
From the registry record, last updated by the sponsor on 26 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact Assessment of the Jockey Club REACH & Map Program for Hard-to-reach Older Adults in the Community: A Target Trial Emulation
- ClinicalTrials.gov ID
- NCT07305441
- Acronym / sponsor ID
- REACH & MAP
- Conditions
- Hard-to-Reach Elderly
- Keywords
- Hard-to-Reach, elderly, functional status
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 5,500 participants (estimated)
- Lead sponsor
- The University of Hong KongUniversity, hospital or other
- Study start
- 5 Feb 2024 (actual)
- Primary completion
- 30 Sep 2027 (estimated)
- Study completion
- 31 Jan 2028 (estimated)
- First posted
- 26 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to evaluate the impact of the Reach-and-Map project on increasing functional capacity to optimize the functional ability of the vulnerable group of "Hard-to-Reach" older adults through increase the compatibility between their intrinsic capacity and environment.
Detailed description
The overall aim of this project is to conduct a comprehensive impact assessment of the Jockey Club (JC) Reach \& Map Program, utilizing a framework based on the World Health Organization (WHO) Health Impact Assessment. The study will evaluate how the program influences health outcomes among hard-to-reach older adults by assessing changes in key health determinants. The findings will be disseminated to relevant stakeholders to inform future policy setting and service planning, and long-term monitoring will be undertaken to evaluate the extent to which the impact assessment influences decision-making in aged care service development.
The primary focus of the evaluation is on the functional abilities of older adults, including physical, cognitive, psychological, and social functioning. The assessment will also cover core outcomes such as quality of life, frailty, and health service use, alongside person-centered measures like loneliness and mental health. Given the diverse services received by beneficiaries, the study will account for structural and social health determinants-such as age, gender, socio-economic status, and chronic disease burden-as covariates in the analysis. In addition, the project will explore the broader effects of the JC Reach \& Map Program on aged care service utilization and document both the experiences of service recipients and stakeholders involved.
Specifically, the study objectives are: (1) to evaluate the impact of the JC Reach \& Map Program on frailty, quality of life, and health service use among hard-to-reach older adults, focusing on physical, cognitive, psychological, and social functions; (2) to explore the engagement experiences and perceptions of older adults regarding the services received, and their impact on well-being, community engagement, and social integration; and (3) to explore the experiences of service stakeholders in reaching and working with this population, as well as to gather their insights on ideal service models and policies for hard-to-reach older adults.
Study design
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Treatment status | Experimental | Behavioral: Mapped intervention based on health statusTo account for time bias, each subject will be created with two clones at time zero and assigned each of the two clones to either treatment or no-treatment status, respectively. The treatment status in each evaluative endpoint (i.e., 1-month, 4-month, 10-month, and 13-month) is defined as subjects who have received the mapped intervention for the respective length of time since the time zero during which the intervention has just commenced. |
| No-treatment status | No intervention | –To account for immortal time bias, each subject will be created with two clones at time zero and assigned each of the two clones to either treatment or no-treatment status, respectively. The corresponding no-treatment status is defined as subjects who have not received any mapped intervention for the corresponding length of time. |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- age > 60
- able to participate in the impact assessment as evidence by a test score of > 6 on the Abbreviated Mental Test
- has the functional ability to engage in the digital intervention
- able to communicate with the researcher
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mapped intervention based on health statusIntervention will be conducted to improve lifestyle based on their needs which include 1) Home modification, 2) Lifestyle-based health promotion, 3) Geriatric symptom management, 4) Health counseling for chronic disease management, 5) Counseling-based service, 6) Social network optimization, 7) Social support optimization | Behavioural | Treatment status |
Primary outcome
EuroQoL-5 Dimension-5 Level
Time frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Measuring Health-related quality of life (HRQL) (range from -0.59 to 1.0), higher score indicates better quality of life
Short Physical Performance Battery
Time frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Measuring by (range from 0 to 12), with higher score indicating better physical performance
5-minute Montreal Cognitive Assessment (MoCA)
Time frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Measuring Cognitive function (range from 0 to 30), A score of 26 or over is considered to be normal.
7-item Memory Complaint Scale (MCS)
Time frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Measuring Subjective Memory Score (range from 0 to 14), lower score indicates better memory performance. No MCs (0-2), Mild MCs (3-6), Moderate MCs (7-10), Severe MCs (11-14).
3-item University of California, Los Angeles (UCLA) Loneliness Scale
Time frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Measuring Loneliness (range 3-9), higher score indicates greater loneliness.
The 8-item Geriatric Depression Scale
Time frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Measuring Depression (range 0 to 8), with higher score indicating higher risk of depression
8-item Social Connectedness Scale Revised
Time frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Measuring Social connectedness (range 0 to 48), <22 indicates lack of social connectedness
2 secondary outcomes
Health service utilization
Time frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Health service utilization
Time frame: From baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Dec 2025.
- Individual participant dataSharing planned: No. There is not a plan to make individual participant data (IPD) available to other researchers.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Doris Sau Fung YU principal investigator
The University of Hong Kong
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mapped intervention based on health status in people with Hard-to-Reach Elderly, run by The University of Hong Kong at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 26 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Doris Sau Fung YU, PhD (852-3917-6319, dyu1@hku.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
EuroQoL-5 Dimension-5 Level (time frame: Changes from baseline to 1 month, 4 month, 10 month, and 13 month post-intervention.). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Dec 2025.